Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Valproic acid and crocin together boost cell growth and may help treat nerve injuries.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Recombinant collagen with nicotinamide boosts hair growth and health.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Neuropeptides affect hair growth and could be used to control it.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.